Acadia Pharmaceuticals
ACAD
ACAD
247 hedge funds and large institutions have $3.25B invested in Acadia Pharmaceuticals in 2023 Q3 according to their latest regulatory filings, with 40 funds opening new positions, 93 increasing their positions, 73 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
13% less funds holding in top 10
Funds holding in top 10: 8 → 7 (-1)
15% less capital invested
Capital invested by funds: $3.81B → $3.25B (-$558M)
41% less call options, than puts
Call options by funds: $33.5M | Put options by funds: $56.7M
Holders
247
Holding in Top 10
7
Calls
$33.5M
Puts
$56.7M
Top Buyers
| 1 | +$40.1M | |
| 2 | +$37.4M | |
| 3 | +$19.1M | |
| 4 |
HRCM
Hood River Capital Management
Palm Beach Gardens,
Florida
|
+$18.3M |
| 5 |
FAM
Fred Alger Management
New York
|
+$18.1M |
Top Sellers
| 1 | -$85.1M | |
| 2 | -$39M | |
| 3 | -$27.7M | |
| 4 |
WP
Woodline Partners
San Francisco,
California
|
-$19.9M |
| 5 |
First Trust Advisors
Wheaton,
Illinois
|
-$18.2M |